Josep M. Martinez
University of Barcelona
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Josep M. Martinez.
European Journal of Obstetrics & Gynecology and Reproductive Biology | 2003
Francesc Figueras; B. Puerto; Josep M. Martinez; V. Cararach; Juan A. Vanrell
OBJECTIVE To describe the time sequence of changes in cardiac function in intrauterine growth restriction. STUDY DESIGN This was a prospective longitudinal study on 22 singleton pregnancies with growth-restricted fetuses. Pulsatility indices of fetal arterial and venous Doppler waveforms, systolic peak velocity in the aorta and pulmonary artery, right and left ventricular shortening fraction and atrioventricular flow E/A ratio were assessed at each monitoring session. Logistic regression was used for modeling the probability of abnormality of a variable in relation to the time interval before delivery. Trends over time were analyzed by Mann-Withney U-test. RESULTS Umbilical artery pulsatility index was the first variable to become abnormal, followed by the middle cerebral artery, right diastolic indices (right E/A, ductus venosus), right systolic indices and, finally, both diastolic and systolic left cardiac indices. CONCLUSION We have found an earlier and more pronounced right than left and diastolic than systolic fetal cardiac function deterioration in growth restricted fetuses monitored longitudinally.
Ultrasound in Obstetrics & Gynecology | 2004
Keisuke Ishii; Ramen H. Chmait; Josep M. Martinez; Masahiko Nakata; Ruben Quintero
To estimate direction and volume of blood exchange between the donor twin and recipient twin by ultrasound assessment of blood flow in the umbilical vein before and after selective laser photocoagulation of communicating vessels (SLPCV) for twin–twin transfusion syndrome (TTTS).
Prenatal Diagnosis | 1999
Elena Casals; Carlos Aibar; Josep M. Martinez; Antoni Borrell; Anna Soler; Julia Ojuel; Antonio M. Ballesta; Albert Fortuny
The value of maternal serum pregnancy‐associated protein A (PAPP‐A), free and total β human chorionic gonadotrophin (fβhCG, βhCG) and α‐fetoprotein (AFP) in screening for Down syndrome (DS) in early pregnancy has been assessed. To evaluate the different biochemical markers, 32 DS pregnancies and 267 controls were used for AFP, βhCG and PAPP‐A. A subgroup of those (17 DS and 136 controls) were used to evaluate fβhCG. All analytes were determined in fresh serum samples. Our results give support to the feasibility of maternal serum levels of PAPP‐A as the best biochemical marker for DS in the first trimester, and either βhCG or fβhCG as the second marker. No differences were found between βhCG and fβhCG distribution levels as expressed as MoMs in normal and DS pregnancies in this study. Copyright
Ultrasound in Obstetrics & Gynecology | 2010
R. Cruz‐Martinez; O. Moreno-Alvarez; Edgar Hernandez-Andrade; Montserrat Castañón; Elisa Done; Josep M. Martinez; B. Puerto; Jan Deprest; Eduard Gratacós
To evaluate the contribution of intrapulmonary artery Doppler in predicting the survival of fetuses with congenital diaphragmatic hernia (CDH) treated with fetoscopic tracheal occlusion (FETO).
Prenatal Diagnosis | 2010
Dan V. Valsky; Elisenda Eixarch; Josep M. Martinez; Eduard Gratacós
Selective intrauterine growth restriction (sIUGR) occurs in 10 to 15% of monochorionic (MC) twins, and it is associated with a substantial increase in perinatal mortality and morbidity. Clinical evolution is largely influenced by the existence of intertwin placental anastomoses: pregnancies with similar degrees of fetal weight discordance are associated with remarkable differences in clinical behavior and outcome. We have proposed a classification of sIUGR into three types according to umbilical artery (UA) Doppler findings (I‐normal, II‐absent/reverse end‐diastolic flow, III‐intermittent absent/reverse end‐diastolic flow), which correlates with distinct clinical behavior, placental features and may assist in counseling and management. In terms of prognosis, sIUGR can roughly be divided in two groups: type I cases, with a fairly good outcome, and types II and III, with a substantial risk for a poor outcome. Management of types II and III may consist in expectant management until deterioration of the IUGR fetus is observed, with the option of cord occlusion if this occurs before viability. Alternatively, active management can be considered electively, including cord occlusion or laser coagulation. Both therapies seem to increase the chances of intact survival of the larger fetus, while they entail, or increase the chances of, intrauterine demise of the IUGR fetus. Copyright
Fetal Diagnosis and Therapy | 2011
R. Cruz‐Martinez; O. Moreno-Alvarez; Edgar Hernandez-Andrade; Montserrat Castañón; Josep M. Martinez; Elisa Done; Jan Deprest; Eduard Gratacós
Objective: To assess the impact of lung perfusion by fractional moving blood volume (FMBV) for the prediction of survival in fetuses with congenital diaphragmatic hernia (CDH) treated with fetal endoscopic tracheal occlusion (FETO). Study Design: Lung perfusion by FMBV (%) and the observed/expected lung-to-head ratio (o/e LHR) were evaluated 1 day before and 7–14 days after FETO in a cohort of 62 CDH fetuses, and their isolated and combined values to predict survival was assessed. Results: Preoperative lung perfusion did not show association with survival. However, after FETO, an increase in 30% of the preoperative lung FMBV and an increase in 50% of the LHR was significantly associated with the probability of survival. A model combining the changes in FMBV and o/e LHR after therapy allowed discrimination of cases with poor (10% survival), moderate (40–70% survival) and very good prognosis (100% survival). Conclusion:Changes in lung tissue perfusion, evaluated by FMBV after FETO, improved the prediction of survival in fetuses with CDH.
Fetal Diagnosis and Therapy | 2015
N. Masoller; Magda Sanz-Cortés; Fatima Crispi; O. Gómez; M. Bennasar; Gabriela Egaña-Ugrinovic; Nuria Bargalló; Josep M. Martinez; Eduard Gratacós
Objectives: We evaluated the hypothesis that in fetuses with congenital heart disease (CHD) there is a correlation between the expected pattern of in utero brain blood supply and the severity of neurodevelopmental impairment. Methods: A total of 58 fetuses with CHD and 58 controls underwent a Doppler ultrasound and fetal MRI at 36-38 weeks. Fetuses with CHD were divided into two functional classes: class A with an expected severe reduction in oxygenated brain blood supply (left outflow tract obstruction and transposition of great vessels) and class B with theoretically near-normal or mildly impaired oxygenated brain blood supply (other CHD). Head biometry and cerebroplacental Doppler were assessed by ultrasound, and brain volumetry, cortical development and metabolism by MRI. Results: Both class A and B CHD fetuses had significant differences in head biometry, brain perfusion, cortical development and brain metabolism compared with controls. However, there was a significant linear tendency for head biometry, cerebral Doppler, volumes, cortical sulcation and metabolic ratios across the three clinical groups, with signs of more severe brain alterations in type A CHD fetuses. Conclusions: All fetuses with CHD showed significant brain developmental changes, but differences were more pronounced in CHD associated with an expected severe reduction in oxygenated blood supply to the brain.
Ultrasound in Obstetrics & Gynecology | 2004
Masahiko Nakata; Josep M. Martinez; C. Díaz; Ramen H. Chmait; Ruben Quintero
twin gestations (Abstract). Cardiol Young 2002; 12 (Suppl. 1): 42. 6. Simpson JM. Hypoplastic left heart syndrome (Editorial). Ultrasound Obstet Gynecol 2000; 15: 271–278. 7. Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH. Using fetal nuchal translucency for major congenital cardiac defects at 10–14 weeks of gestation: population based cohort study. BMJ 1999; 318: 81–85. 8. Sullivan ID. Prenatal diagnosis of structural heart disease: does it make a difference to survival? (Editorial). Heart 2002; 87: 405–406. 9. Andrews R, Tulloh R, Sharland G, Simpson J, Baker E, Qureshi S, Rosenthal E, Austin C, Anderson D. Outcome of staged reconstructive surgery for hypoplastic left heart syndrome following antenatal diagnosis. Arch Dis Child 2001; 85: 474–477; correction and update, Arch Dis Child 2002; 86: 313.
Prenatal Diagnosis | 2008
S. Fernandez; Francesc Figueras; O. Gómez; Josep M. Martinez; Elisenda Eixarch; Montserrat Comas; B. Puerto; Eduard Gratacós
To assess the intra‐ and interobserver reliability of the umbilical vein (UV) diameter, time‐averaged maximum velocity (TAMX) and umbilical vein blood flow (BF).
Fetal Diagnosis and Therapy | 2005
María del Río Holgado; Josep M. Martinez; O. Gómez; Gemma Casals; Nuria Bargalló; Albert Fortuny; B. Puerto
Jarcho-Levin syndrome (JLS; spondylothoracic dysplasia) is a congenital disease characterized by multiple vertebral and rib malformations, causing a short trunk dwarfism commonly leading to respiratory insufficiency and death during the first years of life. We describe a case diagnosed during the second trimester routine ultrasound scan for screening of fetal anomalies without a previous family history. The fetus had a severe disorganization of the spine and ribs, skeletal kyphosis, with several hemivertebrae and a small thorax. All of the findings at postmortem examination confirmed the ultrasound features and were consistent with the JLS. To the best of our knowledge there is only one case reported in the literature of a prenatal diagnosis of the syndrome in a family with low risk for the condition.